Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution

BACKGROUND: Although implementation of temozolomide (TMZ) as a part of primary therapy for glioblastoma multiforme (GBM) has resulted in improved patient survival, the disease is still incurable. Previous studies have correlated various parameters to survival, although no single parameter has yet be...

Descripción completa

Detalles Bibliográficos
Autores principales: Michaelsen, Signe Regner, Christensen, Ib Jarle, Grunnet, Kirsten, Stockhausen, Marie-Thérése, Broholm, Helle, Kosteljanetz, Michael, Poulsen, Hans Skovgaard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766209/
https://www.ncbi.nlm.nih.gov/pubmed/24004722
http://dx.doi.org/10.1186/1471-2407-13-402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766209/
https://www.ncbi.nlm.nih.gov/pubmed/24004722
http://dx.doi.org/10.1186/1471-2407-13-402

Ejemplares similares